Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma
Status:
Recruiting
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if radiation therapy and chemotherapy
can help control Stage 1 and/or 2 NK cell lymphoma. The safety of the radiation and
chemotherapy combination will also be studied.
This is an investigational study. Radiation and chemotherapy are FDA approved and
commercially available for patients with Stage 1 and/or 2 NK cell lymphoma. The combination
of these therapies given at the same time is investigational.
Up to 40 patients will take part in this study. All will be enrolled at MD Anderson.